IP Library Granted Patent US 7,842,797
Granted Patent B2
US 7,842,797 · App. 12/395,214 · Granted Nov 30, 2010

Human CDR-grafted antibody and antibody fragment thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,842,797
App. No.
12/395,214
Granted
Nov 30, 2010
Kind
B2
Abstract

A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.

Claims (6)

1. A DNA encoding a human CDR-grafted antibody, or antigen-binding fragment thereof, which reacts with an extracellular region of human CC chemokine receptor 4 (CCR4), but does not specifically react with a human platelet, wherein said antibody or antigen-binding fragment thereof comprises an antibody heavy chain (H chain) variable region (V region) comprising the amino acid sequence of SEQ ID NO: 4, 9, 10, 11, 38, 39, 40 or 41.

2. The DNA of claim 1 , wherein the polynucleotide sequence of said DNA which encodes said heavy chain (H chain) variable region (V region) comprises the polynucleotide sequence of SEQ ID NO: 50, 51, 52, 58, 59 or 60.

3. A DNA encoding a human CDR-grafted antibody, or antigen-binding fragment thereof, which reacts with an extracellular region of human CC chemokine receptor 4 (CCR4), but does not specifically react with a human platelet, wherein said antibody or antigen-binding fragment thereof comprises an antibody light chain (L chain) variable region (V region) comprising the amino acid sequence of SEQ ID NO: 8, 12, 13 or 14.

4. The DNA of claim 3 , wherein the polynucleotide sequence of said DNA which encodes said light chain (L chain) variable region (V region) comprises the polynucleotide sequence of SEQ ID NO: 54, 55 or 56.

5. A DNA which encodes the antibody produced by a transformant KM8759 (FERM BP-8129) or KM8760 (FERM BP-8130), or an antigen-binding fragment thereof.

6. A recombinant vector which comprises the DNA of any one of claims 1 - 5 .

Assignments (1)
CHANGE OF NAME AND ADDRESS Recorded Oct 23, 2019
From: KYOWA HAKKO KIRIN CO., LTD.
To: KYOWA KIRIN CO., LTD.
Reel/Frame 050797/0533 →